Form 4 for LNAI Lunai Bioworks Inc.
Accepted 2023-02-06 00:00:00 ET · period of report 2022-10-13 · accession 0001214659-23-001677 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-02-06 | 2022-10-13 | LNAI | William Anderson Wittekind | 10% | J - Other | — | +1.22M | 1.31M | +1,254% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-13 | J | A | 1,216,467 | — | 1,313,499 | I Weird Science LLC | — | — | (F1) Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement. (F2) The Reporting Person is a manager of Weird Science LLC. |